Literature DB >> 15682512

Cancer vaccines: pessimism in check.

John M Timmerman, Ronald Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15682512     DOI： 10.1038/nm1204-1279a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

Authors:  Li-Xin Wang; Rui Li; Guojun Yang; May Lim; Aisling O'Hara; Yiwei Chu; Bernard A Fox; Nicholas P Restifo; Walter J Urba; Hong-Ming Hu
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

2.  Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sites.

Authors:  Anahit Ghochikyan; Mikayel Mkrtichyan; Dmitri Loukinov; Gregory Mamikonyan; Svetlana D Pack; Nina Movsesyan; Thomas E Ichim; David H Cribbs; Victor V Lobanenkov; Michael G Agadjanyan
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

3.  Primary 4T1 tumor resection provides critical "window of opportunity" for immunotherapy.

Authors:  Anahit Ghochikyan; Arpine Davtyan; Armine Hovakimyan; Hayk Davtyan; Anna Poghosyan; Alexander Bagaev; Ravshan I Ataullakhanov; Edward L Nelson; Michael G Agadjanyan
Journal:  Clin Exp Metastasis       Date:  2013-10-06       Impact factor: 5.150

Review 4.  Harnessing the immune system to improve cancer therapy.

Authors:  Nikos E Papaioannou; Ourania V Beniata; Panagiotis Vitsos; Ourania Tsitsilonis; Pinelopi Samara
Journal:  Ann Transl Med       Date:  2016-07

Review 5.  Clinical applications of a peptide-based vaccine for glioblastoma.

Authors:  Charles W Kanaly; Dale Ding; Amy B Heimberger; John H Sampson
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

Review 6.  EGFRvIII-targeted vaccination therapy of malignant glioma.

Authors:  Bryan D Choi; Gary E Archer; Duane A Mitchell; Amy B Heimberger; Roger E McLendon; Darell D Bigner; John H Sampson
Journal:  Brain Pathol       Date:  2009-10       Impact factor: 6.508

Review 7.  Anaplastic lymphoma kinase: an oncogene for tumor vaccination.

Authors:  Cristina Mastini; Cinzia Martinengo; Giorgio Inghirami; Roberto Chiarle
Journal:  J Mol Med (Berl)       Date:  2009-03-30       Impact factor: 4.599

8.  A balanced review of the status T cell-based therapy against cancer.

Authors:  Francesco M Marincola
Journal:  J Transl Med       Date:  2005-04-14       Impact factor: 5.531

Review 9.  Cancer vaccines.

Authors:  Lisa H Butterfield
Journal:  BMJ       Date:  2015-04-22

Review 10.  Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells-An Update.

Authors:  Jan Dörrie; Niels Schaft; Gerold Schuler; Beatrice Schuler-Thurner
Journal:  Pharmaceutics       Date:  2020-01-23       Impact factor: 6.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.